Clinical Trials in Cleveland

Showing 3881-3900 of 15,050 trials

Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease

NCT06694558

This is a cross-sectional study in patients with Type 1 diabetes (TID) and chronic kidney disease (CKD) to test if time in range (TIR) affects the degree of hyperglycemia required for monocyte activation, podocyte injury, and assess if monocyte activation is attenuated by glucagon-like peptide (GLP-1) agonist treatment ex vivo.

Chronic Kidney Disease(CKD)Type 1 Diabetes (T1D)

The Cleveland Clinic60 participantsStarted Mar 2025

Cleveland, Ohio, United States

Active Not Recruiting< 1 mile

Validation of a Multi-gene Test for Lung Cancer Risk

NCT01130285

The purpose of this study is to determine the validity of a multi-gene Lung Cancer Risk Test (LCRT). In the process, the investigators will establish a bank of NBEC samples and corresponding blood samples from individuals demographically at increased risk for lung cancer.

Lung Cancer

University of Toledo Health Science Campus403 participantsStarted May 2011

Denver, Colorado, United States • Ann Arbor, Michigan, United States • Detroit, Michigan, United States +10 more locations

RECRUITINGNA< 1 mile

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

NCT06137807

The TricValve® Transcatheter Bicaval Valve System is a bicaval transcatheter tricuspid valve replacement system, which includes the TricValve® Transcatheter Bicaval Valve for superior vena cava (SVC) and the TricValve® Transcatheter Bicaval Valve for inferior vena cava (IVC). The TricValve® Transcatheter Bicaval Valves are pre-mounted into the TricValve® Delivery System which is used for percutaneous access and delivery of the TricValve® Transcatheter Bicaval Valve in the vena cava. The system is a single use, sterile device compatible with all the valve sizes. The prostheses are implanted percutaneously into the inferior and superior vena cava without disturbing the native tricuspid valve. The device is made of bovine pericardium leaflets sutured on a nitinol self-expanding stent system.

Tricuspid RegurgitationTricuspid Valve Disease

P+F Products + Features USA Inc.50 participantsStarted Jul 2024

Phoenix, Arizona, United States • Tucson, Arizona, United States • San Diego, California, United States +33 more locations

Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease

Validation of a Multi-gene Test for Lung Cancer Risk

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

Find Trials by Condition in Cleveland

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Medical Access Program for Patritumab Deruxtecan

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

Natural History Study of Synucleinopathies

Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

TAC T-cells for the Treatment of HER2-positive Solid Tumors

Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

AVID100 in Advanced Epithelial Carcinomas

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)

ProVIDE II Bridging Study

Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer

Promoting Shared Decision Making for Severe Aortic Stenosis

ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies

VB-111 in Surgically Accessible Recurrent/Progressive GBM